These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17587246)

  • 21. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
    Osunkoya AO; Nielsen ME; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case study: management of lymph node-positive disease detected at radical prostatectomy.
    Kirby R
    Prostate Cancer Prostatic Dis; 2005; 8(3):287-9. PubMed ID: 15940288
    [No Abstract]   [Full Text] [Related]  

  • 23. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
    Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.
    Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G
    Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma.
    Cohn DE; Folpe AL; Gown AM; Goff BA
    Gynecol Oncol; 1998 Feb; 68(2):210-3. PubMed ID: 9514806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphadenectomy and prostate cancer: a statement of the committee of cancerology of the French Association of Urology].
    Salomon L; Peyromaure M; Fromont G; Rozet F; Eiss D; Bastide C; Beuzeboc P; Gachignard N; Cormier L; Hennequin C; Mongiat-Artus P; Soulié M; ;
    Prog Urol; 2012 Jul; 22(9):510-9. PubMed ID: 22732642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pelvic lymphadenectomy in prostate cancer management.
    Sivalingam S; Oxley J; Probert JL; Stolzenburg JU; Schwaibold H
    Urology; 2007 Feb; 69(2):203-9. PubMed ID: 17320652
    [No Abstract]   [Full Text] [Related]  

  • 29. [Locoregional staging of prostatic neoplasms by extemporaneous histological examination of pelvic lymph nodes].
    Zattoni F; Pegoraro V; Guazzieri S; Dal Bianco M
    J Urol (Paris); 1985; 91(3):155-6. PubMed ID: 4045210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allergic vasculitis in benign prostatic hyperplasia combined with a latent prostatic carcinoma].
    Shmurun RI
    Urol Nefrol (Mosk); 1997; (5):46-9. PubMed ID: 9412017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy.
    Vaghefi H; Magi-Galluzzi C; Klein EA
    Urology; 2005 Oct; 66(4):881. PubMed ID: 16230172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic image (52). Metallosis of a lymph gland].
    Eulderink F
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1638. PubMed ID: 11552365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phyllodes tumor of the prostate with exuberant glandular hyperplasia.
    Morikawa T; Nagata M; Tomita K; Kitamura T; Goto A; Chong JM; Fukayama M
    Pathol Int; 2006 Mar; 56(3):158-61. PubMed ID: 16497250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Florid xanthomatous pelvic lymph node reaction to metastatic prostatic adenocarcinoma. A sequela of preoperative androgen deprivation therapy.
    Schned AR; Gormley EA
    Arch Pathol Lab Med; 1996 Jan; 120(1):96-100. PubMed ID: 8554456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
    Gupta A; Karakiewicz PI; Roehrborn CG; Lotan Y; Zlotta AR; Shariat SF
    Clin Cancer Res; 2008 Nov; 14(22):7385-90. PubMed ID: 19010854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy].
    Winter A; Uphoff J; Henke RP; Wawroschek F
    Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of periprostatic and periseminal vesicle lymph node metastasis in the staging and prognosis of prostate cancer.
    Subik MK; Yao JL; di Sant'Agnese PA; Miyamoto H
    Histopathology; 2012 May; 60(6):1009-10. PubMed ID: 22372986
    [No Abstract]   [Full Text] [Related]  

  • 39. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical (carcinoma-like) and simple glandular inclusions in retroperitoneal lymph nodes.
    Horn LC; Bilek K
    Gen Diagn Pathol; 1996 May; 141(5-6):319-25. PubMed ID: 8780931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.